Related Experiment Videos
Human hybrid immunoglobulin M containing immunoglobulin A
H Shinmoto1, H Murakami, S Dosako
1Technical Research Institute, Snow Brand Milk Products Co., Ltd., Kawagoe, Japan.
Summary
Hybridoma cell fusion produced novel immunoglobulin molecules with characteristics of both IgA and IgM. These hybrid immunoglobulins exhibited unique structures, suggesting potential for new therapeutic applications in immunology.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Hybridoma technology is crucial for producing monoclonal antibodies.
- Understanding immunoglobulin structure and function is key to immune system research.
Purpose of the Study:
- To characterize novel immunoglobulin molecules secreted by hybridomas.
- To investigate the structural composition of IgM-like molecules.
Main Methods:
- Hybridoma cell fusion (HO323 lymphoblastoid cells with human B lymphocytes).
- Immunochemical analyses to determine molecular composition.
- Molecular size determination (900 K).
Main Results:
- Hybridomas secreted hybrid immunoglobulin molecules with both IgA and IgM characteristics.
- The IgM-like molecules had a molecular weight of 900 K, consistent with IgM.
- Immunochemical analysis showed these molecules comprised two monomeric IgA and three monomeric IgM units.
- Light chain exchange was observed between IgA and IgM moieties.
Conclusions:
- Hybridoma technology can generate novel immunoglobulin constructs with mixed IgA and IgM features.
- These findings expand our understanding of immunoglobulin diversity and B cell fusion products.
- The characterized hybrid immunoglobulins may offer new avenues for immunotherapeutic strategies.